Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (20)
Hatem Kaseb, Valeria Visconte, Daniel S. Socha, Genevieve M. Crane, Lisa Durkin, James R. Cook, Jaroslaw P. Maciejewski, Eric D. Hsi & Heesun J. Rogers. (2023)
The clinicopathologic significance of
NPM1
mutation and ability to detect mutated
NPM1
by immunohistochemistry in
non‐AML
myeloid neoplasms
. Genes, Chromosomes and Cancer 62:10, pages 573-580.
Crossref
Crossref
Ugo Testa, Elvira Pelosi & Germana Castelli. (2023) Genetic, Phenotypic, and Clinical Heterogeneity of NPM1-Mutant Acute Myeloid Leukemias. Biomedicines 11:7, pages 1805.
Crossref
Crossref
Claudia Bănescu, Florin Tripon & Carmen Muntean. (2023) The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia. International Journal of Molecular Sciences 24:6, pages 5734.
Crossref
Crossref
Nehakumari Maurya, Purvi Mohanty, Somprakash Dhangar, Purvi Panchal, Farah Jijina, S. Leo Prince Mathan, Chandrakala Shanmukhaiah, Manisha Madkaikar & Babu Rao Vundinti. (2022) Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes. Scientific Reports 12:1.
Crossref
Crossref
Katalin Kelemen. (2022) The Role of Nucleophosmin 1 (NPM1) Mutation in the Diagnosis and Management of Myeloid Neoplasms. Life 12:1, pages 109.
Crossref
Crossref
Daniel R. Richardson & Amy E. DeZern. (2021) Evidence-Based Minireview: Molecular precision and clinical uncertainty: should molecular profiling be routinely used to guide risk stratification in MDS?. Hematology 2021:1, pages 435-438.
Crossref
Crossref
Fabio Forghieri, Giovanni Riva, Ivana Lagreca, Patrizia Barozzi, Francesca Bettelli, Ambra Paolini, Vincenzo Nasillo, Beatrice Lusenti, Valeria Pioli, Davide Giusti, Andrea Gilioli, Corrado Colasante, Laura Galassi, Hillary Catellani, Francesca Donatelli, Annalisa Talami, Rossana Maffei, Silvia Martinelli, Leonardo Potenza, Roberto Marasca, Enrico Tagliafico, Rossella Manfredini, Tommaso Trenti, Patrizia Comoli & Mario Luppi. (2021) Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid Leukemia. International Journal of Molecular Sciences 22:17, pages 9159.
Crossref
Crossref
Vincenzo Nasillo, Giovanni Riva, Ambra Paolini, Fabio Forghieri, Luca Roncati, Beatrice Lusenti, Monica Maccaferri, Andrea Messerotti, Valeria Pioli, Andrea Gilioli, Francesca Bettelli, Davide Giusti, Patrizia Barozzi, Ivana Lagreca, Rossana Maffei, Roberto Marasca, Leonardo Potenza, Patrizia Comoli, Rossella Manfredini, Antonino Maiorana, Enrico Tagliafico, Mario Luppi & Tommaso Trenti. (2021) Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel Immunotherapies. International Journal of Molecular Sciences 22:4, pages 1906.
Crossref
Crossref
Brunangelo Falini, Lorenzo Brunetti & Maria Paola Martelli. (2021)
How I diagnose and treat
NPM1
-mutated AML
. Blood 137:5, pages 589-599.
Crossref
Crossref
Fabio Forghieri, Vincenzo Nasillo, Ambra Paolini, Francesca Bettelli, Valeria Pioli, Davide Giusti, Andrea Gilioli, Corrado Colasante, Gloria Acquaviva, Giovanni Riva, Patrizia Barozzi, Rossana Maffei, Leonardo Potenza, Roberto Marasca, Claudio Fozza, Enrico Tagliafico, Tommaso Trenti, Patrizia Comoli, Giuseppe Longo & Mario Luppi. (2020) NPM1-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?. International Journal of Molecular Sciences 21:23, pages 8975.
Crossref
Crossref
Brunangelo Falini, Lorenzo Brunetti, Paolo Sportoletti & Maria Paola Martelli. (2020) NPM1-mutated acute myeloid leukemia: from bench to bedside. Blood 136:15, pages 1707-1721.
Crossref
Crossref
Gina Jiang, Jose-Mario Capo-Chichi, Aijun Liu, Eshetu G. Atenafu, Robert Guo, Ann Tierens, Mark D. Minden & Hong Chang. (2020) Acute myeloid leukemia with myelodysplasia-related changes diagnosed with multilineage dysplasia alone demonstrates a superior clinical outcome. Human Pathology 104, pages 117-126.
Crossref
Crossref
Sanjay S. Patel, Michael J. Kluk & Olga K. Weinberg. (2020) NPM1 Biology in Myeloid Neoplasia. Current Hematologic Malignancy Reports 15:4, pages 350-359.
Crossref
Crossref
Sang Mee Hwang, Sung-Min Kim, Youngwon Nam, Jinhyun Kim, Sungsik Kim, Yong-Oon Ahn, Yong Park, Sung-Soo Yoon, Sue Shin, Sunghoon Kwon & Dong Soon Lee. (2019) Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemia. Leukemia Research 84, pages 106190.
Crossref
Crossref
Sanjay S. PatelCaleb Ho, Ryan N. PtashkinSam SadighAdam BaggJulia T. GeyerMina L. Xu, Thomas PrebetEmily F. MasonAdam C. SeegmillerElizabeth A. Morgan, David P. SteensmaEric S. WinerWaihay J. WongRobert P. Hasserjian & Olga K. Weinberg. (2019) Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms. Blood Advances 3:9, pages 1540-1545.
Crossref
Crossref
Guillermo Montalban-Bravo, Rashmi Kanagal-ShamannaKoji Sasaki, Keyur PatelIrene Ganan-Gomez, Elias Jabbour, Tapan Kadia, Farhad Ravandi, Courtney DiNardo, Gautham Borthakur, Koichi Takahashi, Marina Konopleva, Rami S. KomrokjiAmy DeZern, Teodora Kuzmanovic, Jaroslaw Maciejewski, Sherry Pierce, Simona Colla, Mikkael A. Sekeres, Hagop Kantarjian, Carlos Bueso-RamosGuillermo Garcia-Manero. (2019) NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy. Blood Advances 3:6, pages 922-933.
Crossref
Crossref
Fabio Forghieri, Giovanni Riva, Ivana Lagreca, Patrizia Barozzi, Daniela Vallerini, Monica Morselli, Ambra Paolini, Paola Bresciani, Elisabetta Colaci, Monica Maccaferri, Andrea Gilioli, Vincenzo Nasillo, Andrea Messerotti, Valeria Pioli, Laura Arletti, Davide Giusti, Francesca Bettelli, Melania Celli, Francesca Donatelli, Giorgia Corradini, Sabrina Basso, Antonella Gurrado, Monica Cellini, Tommaso Trenti, Roberto Marasca, Franco Narni, Maria Paola Martelli, Brunangelo Falini, Leonardo Potenza, Mario Luppi & Patrizia Comoli. (2019) Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia. Oncotarget 10:8, pages 869-882.
Crossref
Crossref
Maria Sanz-De Pedro, Wei Wang, Rashmi Kanagal-Shamanna & Joseph D. Khoury. (2018) Myelodysplastic Syndromes: Laboratory Workup in the Context of New Concepts and Classification Criteria. Current Hematologic Malignancy Reports 13:6, pages 467-476.
Crossref
Crossref
Fabio Forghieri, Patrizia Comoli, Roberto Marasca, Leonardo Potenza & Mario Luppi. (2018) Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives. International Journal of Molecular Sciences 19:11, pages 3492.
Crossref
Crossref
Jay L. Patel, Jonathan A. Schumacher, Kimberly Frizzell, Shelly Sorrells, Wei Shen, Adam Clayton, Rakhi Jattani & Todd W. Kelley. (2017) Coexisting and cooperating mutations in NPM1 -mutated acute myeloid leukemia. Leukemia Research 56, pages 7-12.
Crossref
Crossref